Clinical Trials Browser

Phase 3 × INDUSTRY × nimotuzumab × Clear all

NCT01345084 2025-03-28

NICAP

Phase 3 Withdrawn

Carcinoma, Head and Neck Neoplasms

NCT03413579 2021-08-25

CIMAHOPE

Phase 3 Completed

Uterine Cervical Neoplasms, Neoplasms

NCT01813253 2018-03-26

Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer

Phase 3 Terminated

Gastrointestinal

Stomach Neoplasms